Novavax inks deal with Sanofi for COVID-19 vaccine commercialization, sparking investor interest. NVAX stock analysis predicts mixed outcomes, with some expecting a decline while others anticipate explosive growth. Stay tuned for Thursday's alert, as trading software reviews suggest NVAX stock could reach new highs.